应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01513 丽珠医药
休市中 08-16 16:08:20
24.800
+0.100
+0.40%
最高
24.950
最低
24.600
成交量
13.19万
今开
24.850
昨收
24.700
日振幅
1.42%
总市值
76.15亿
流通市值
76.15亿
总股本
3.07亿
成交额
327.66万
换手率
0.04%
流通股本
3.07亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
南向资金8月14日净卖出丽珠医药17.95万股 连续3日减持
自选股智能写手 · 08-15 09:31
南向资金8月14日净卖出丽珠医药17.95万股 连续3日减持
南向资金8月9日净买入丽珠医药17.18万股 连续3日增持
自选股智能写手 · 08-12
南向资金8月9日净买入丽珠医药17.18万股 连续3日增持
丽珠医药08月09日遭主力抛售210万元 环比增加156.10%
自选股智能写手 · 08-09
丽珠医药08月09日遭主力抛售210万元 环比增加156.10%
【丽珠医药(01513.HK)截至7月末对控股附属公司的担保余额为27.12亿元】智通财经APP讯,丽珠医药(01513.
智通财经 · 08-05
【丽珠医药(01513.HK)截至7月末对控股附属公司的担保余额为27.12亿元】智通财经APP讯,丽珠医药(01513.
丽珠医药(01513)截至7月末对控股附属公司的担保余额为27.12亿元
智通财经 · 08-05
丽珠医药(01513)截至7月末对控股附属公司的担保余额为27.12亿元
丽珠医药(01513)截至7月末累计回购A股共计489.42万股
智通财经 · 08-01
丽珠医药(01513)截至7月末累计回购A股共计489.42万股
【丽珠医药(01513.HK)截至7月末累计回购A股共计489.42万股】智通财经APP讯,丽珠医药(01513.HK)发布公告,截至2024年7月31日,公司通过集中竞价交易方式回购了公司A股股份共计489.
智通财经 · 08-01
【丽珠医药(01513.HK)截至7月末累计回购A股共计489.42万股】智通财经APP讯,丽珠医药(01513.HK)发布公告,截至2024年7月31日,公司通过集中竞价交易方式回购了公司A股股份共计489.
丽珠医药(01513.HK)8月22日举行董事会会议审议及批准半年度业绩
格隆汇资讯 · 08-01
丽珠医药(01513.HK)8月22日举行董事会会议审议及批准半年度业绩
【丽珠医药(01513.HK)7月30日斥资约675.56万元回购A股18.81万股】智通财经APP讯,丽珠医药(01513.
智通财经 · 07-30
【丽珠医药(01513.HK)7月30日斥资约675.56万元回购A股18.81万股】智通财经APP讯,丽珠医药(01513.
南向资金7月29日净买入丽珠医药4.39万股 连续5日增持
自选股智能写手 · 07-30
南向资金7月29日净买入丽珠医药4.39万股 连续5日增持
丽珠医药(01513.HK)于印尼组合营公司 从事原料药生产业务
阿斯达克财经 · 07-30
丽珠医药(01513.HK)于印尼组合营公司 从事原料药生产业务
丽珠医药(01513)及Kalbe拟通过附属公司以现金方式出资在印度尼西亚设立合资公司
智通财经 · 07-29
丽珠医药(01513)及Kalbe拟通过附属公司以现金方式出资在印度尼西亚设立合资公司
【丽珠医药(01513.HK)及Kalbe拟通过附属公司以现金方式出资在印度尼西亚设立合资公司】智通财经APP讯,丽珠医药(01513.
智通财经 · 07-29
【丽珠医药(01513.HK)及Kalbe拟通过附属公司以现金方式出资在印度尼西亚设立合资公司】智通财经APP讯,丽珠医药(01513.
丽珠医药(01513.HK)在印度尼西亚设立合资公司
格隆汇资讯 · 07-29
丽珠医药(01513.HK)在印度尼西亚设立合资公司
丽珠医药(01513)7月29日斥资1257.53万元回购35.18万股A股
智通财经 · 07-29
丽珠医药(01513)7月29日斥资1257.53万元回购35.18万股A股
【丽珠医药(01513.HK)7月29日斥资1257.53万元回购35.18万股A股】智通财经APP讯,丽珠医药(01513.
智通财经 · 07-29
【丽珠医药(01513.HK)7月29日斥资1257.53万元回购35.18万股A股】智通财经APP讯,丽珠医药(01513.
南向资金7月25日净买入丽珠医药10.85万股 连续3日增持
自选股智能写手 · 07-26
南向资金7月25日净买入丽珠医药10.85万股 连续3日增持
【丽珠医药(01513.HK)7月25日斥资1626.26万元回购45万股A股】智通财经APP讯,丽珠医药(01513.HK)发布公告,该公司于2024年7月25日斥资人民币1626.
智通财经 · 07-25
【丽珠医药(01513.HK)7月25日斥资1626.26万元回购45万股A股】智通财经APP讯,丽珠医药(01513.HK)发布公告,该公司于2024年7月25日斥资人民币1626.
丽珠医药07月25日主力资金流出87万元 连续3日减仓
自选股智能写手 · 07-25
丽珠医药07月25日主力资金流出87万元 连续3日减仓
丽珠医药7月24日斥资约1021.24万元回购A股28.1万股
新浪港股 · 07-25
丽珠医药7月24日斥资约1021.24万元回购A股28.1万股
加载更多
公司概况
公司名称:
丽珠医药
所属市场:
SEHK
上市日期:
--
主营业务:
丽珠医药集团股份有限公司是一家主要从事医药产品的研发、生产和销售业务的中国公司。该公司主要产品包括消化道类、心脑血管类、抗微生物药物、促性激素类等西药制剂产品以及中药制剂、原料药和中间体、诊断试剂及设备。该公司的产品销往中国境内和海外市场。
发行价格:
--
{"stockData":{"symbol":"01513","market":"HK","secType":"STK","nameCN":"丽珠医药","latestPrice":24.8,"timestamp":1723795700013,"preClose":24.7,"halted":0,"volume":131900,"delay":0,"floatShares":307052417,"shares":307052417,"eps":2.288314,"marketStatus":"休市中","marketStatusCode":7,"change":0.1,"latestTime":"08-16 16:08:20","open":24.85,"high":24.95,"low":24.6,"amount":3276647,"amplitude":0.01417,"askPrice":24.95,"askSize":11000,"bidPrice":24.8,"bidSize":600,"shortable":3,"etf":0,"ttmEps":2.3178502658591906,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1724031000000},"adr":0,"listingDate":1389801600000,"adjPreClose":24.7,"dividendRate":0.059249,"openAndCloseTimeList":[[1723771800000,1723780800000],[1723784400000,1723795200000]],"volumeRatio":0.345324841041066,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"000513","market":"SZ","secType":"STK","nameCN":"丽珠集团","latestPrice":36.96,"timestamp":1723791834000,"preClose":37,"halted":0,"volume":4003027,"delay":0,"premium":"-38.34"}},"requestUrl":"/m/hq/s/01513","defaultTab":"news","newsList":[{"id":"2459681734","title":"南向资金8月14日净卖出丽珠医药17.95万股 连续3日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2459681734","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459681734?lang=zh_cn&edition=full","pubTime":"2024-08-15 09:31","pubTimestamp":1723685490,"startTime":"0","endTime":"0","summary":"8月14日,南向资金减持丽珠医药17.95万股连续3日减持。截止当日收盘,港股通共持有丽珠医药5395.19万股,占流通股17.56%。港股通减持金额前五个股分别为中国联通、汇丰控股、华能国际电力股份、中国电信、快手-W。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408150940559f2c0d53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408150940559f2c0d53&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01513","BK1191"],"gpt_icon":0},{"id":"2458645925","title":"南向资金8月9日净买入丽珠医药17.18万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2458645925","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458645925?lang=zh_cn&edition=full","pubTime":"2024-08-12 09:31","pubTimestamp":1723426289,"startTime":"0","endTime":"0","summary":"8月9日, 南向资金增持丽珠医药17.18万股,连续3日增持。截止当日收盘,港股通共持有丽珠医药5438.63万股,占流通股17.70%。丽珠医药近5个交易日上涨3.11%,港股通累计增持44.17万股;近20个交易日上涨0.40%,港股通累计增持75.44万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408120941379f22ec06&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408120941379f22ec06&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01513","BK1191"],"gpt_icon":0},{"id":"2458513553","title":"丽珠医药08月09日遭主力抛售210万元 环比增加156.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458513553","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458513553?lang=zh_cn&edition=full","pubTime":"2024-08-09 16:15","pubTimestamp":1723191316,"startTime":"0","endTime":"0","summary":"08月09日, 丽珠医药股价跌0.60%,报收24.90元,成交金额1084万元,换手率0.14%,振幅2.00%,量比0.65。丽珠医药今日主力资金净流出210万元,上一交易日主力净流出82万元,今日环比增加156.10%。该股近5个交易日上涨2.69%,主力资金累计净流出485万元;近20日主力资金累计净流入171万元,其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809161529958b3cb5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809161529958b3cb5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","01513"],"gpt_icon":0},{"id":"2457746407","title":"【丽珠医药(01513.HK)截至7月末对控股附属公司的担保余额为27.12亿元】智通财经APP讯,丽珠医药(01513.","url":"https://stock-news.laohu8.com/highlight/detail?id=2457746407","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457746407?lang=zh_cn&edition=full","pubTime":"2024-08-05 17:13","pubTimestamp":1722849206,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK0239","BK0188","01513","BK1231","BK1161","SG9999001093.SGD","01477","000513","BK0015","601328","BK1574","159938","BK0012","BK0278","BK0183","BK1191","BK0187","09939","BK0020","BK0028","BK1515","03328","BK1560"],"gpt_icon":0},{"id":"2457746206","title":"丽珠医药(01513)截至7月末对控股附属公司的担保余额为27.12亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457746206","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457746206?lang=zh_cn&edition=full","pubTime":"2024-08-05 17:13","pubTimestamp":1722849206,"startTime":"0","endTime":"0","summary":"截至2024年7月31日,公司对控股附属公司的担保余额为27.12亿元,占公司最近一期经审计归属于母公司股东净资产的比例为19.31%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1160019.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","01513"],"gpt_icon":0},{"id":"2456172411","title":"丽珠医药(01513)截至7月末累计回购A股共计489.42万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2456172411","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456172411?lang=zh_cn&edition=full","pubTime":"2024-08-01 16:47","pubTimestamp":1722502048,"startTime":"0","endTime":"0","summary":"智通财经APP讯,丽珠医药(01513)发布公告,截至2024年7月31日,公司通过集中竞价交易方式回购了公司A股股份共计489.42万股,占公司总股本的比例为0.53%,购买的最高价为人民币36.80元/股,最低价为人民币32.95元/股,已使用的资金总额为人民币1.72亿元(不含交易费用)。上述回购符合公司既定的回购股份方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1158715.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["399300","01513","159982","BK1191"],"gpt_icon":0},{"id":"2456172036","title":"【丽珠医药(01513.HK)截至7月末累计回购A股共计489.42万股】智通财经APP讯,丽珠医药(01513.HK)发布公告,截至2024年7月31日,公司通过集中竞价交易方式回购了公司A股股份共计489.","url":"https://stock-news.laohu8.com/highlight/detail?id=2456172036","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456172036?lang=zh_cn&edition=full","pubTime":"2024-08-01 16:47","pubTimestamp":1722502048,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["399300","01513","159982","BK1191"],"gpt_icon":0},{"id":"2456177491","title":"丽珠医药(01513.HK)8月22日举行董事会会议审议及批准半年度业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2456177491","media":"格隆汇资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456177491?lang=zh_cn&edition=full","pubTime":"2024-08-01 16:40","pubTimestamp":1722501655,"startTime":"0","endTime":"0","summary":"格隆汇8月1日丨丽珠医药(01513.HK)公布,谨定于2024年8月22日(星期四)举行董事会会议,藉以审议及批准公司及其附属公司截至2024年6月30日止六个月的未经审计半年度业绩,以及处理其他事项。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408011641099f04ec61&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408011641099f04ec61&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","01513"],"gpt_icon":0},{"id":"2455607518","title":"【丽珠医药(01513.HK)7月30日斥资约675.56万元回购A股18.81万股】智通财经APP讯,丽珠医药(01513.","url":"https://stock-news.laohu8.com/highlight/detail?id=2455607518","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455607518?lang=zh_cn&edition=full","pubTime":"2024-07-30 16:54","pubTimestamp":1722329687,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["159982","BK1191","399300","01513"],"gpt_icon":0},{"id":"2455628004","title":"南向资金7月29日净买入丽珠医药4.39万股 连续5日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2455628004","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455628004?lang=zh_cn&edition=full","pubTime":"2024-07-30 09:31","pubTimestamp":1722303085,"startTime":"0","endTime":"0","summary":"7月29日, 南向资金增持丽珠医药4.39万股,连续5日增持。截止当日收盘,港股通共持有丽珠医药5399.33万股,占流通股17.57%。港股通增持金额前五个股分别为腾讯控股、电能实业、农业银行、工商银行、中国石油化工股份。丽珠医药近5个交易日下跌4.86%,港股通累计增持39.60万股;近20个交易日下跌8.56%,港股通累计增持213.01万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407300943369efa4f29&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407300943369efa4f29&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","01513"],"gpt_icon":0},{"id":"2455644049","title":"丽珠医药(01513.HK)于印尼组合营公司 从事原料药生产业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2455644049","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455644049?lang=zh_cn&edition=full","pubTime":"2024-07-30 08:45","pubTimestamp":1722300300,"startTime":"0","endTime":"0","summary":"丽珠医药公布,全资附属LIAN SGP与PT KALBE FARMA控股附属公司PT GCM签署股东协议,以现金方式出资在印尼设立合资公司。LIAN SGP出资2,612亿印尼盾认购合资公司普通股,占合资公司初始发行股份的80%,PT GCM出资653亿印尼盾,占合资公司初始发行股份的20%。合资公司主要从事原料药生产业务。丽珠医药指,在印尼设立合资公司有利拓展海外业务,符合中长期战略发展的目标。投资尚需取得印尼相关部门批准,能否顺利实施尚存在不确定性。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20240410110807807_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20240410110807807_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1367240/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1191","01513"],"gpt_icon":0},{"id":"2455651641","title":"丽珠医药(01513)及Kalbe拟通过附属公司以现金方式出资在印度尼西亚设立合资公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2455651641","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455651641?lang=zh_cn&edition=full","pubTime":"2024-07-29 20:02","pubTimestamp":1722254524,"startTime":"0","endTime":"0","summary":"智通财经APP讯,丽珠医药 发布公告,2024年7月29日,该公司全资附属公司LIAN SGP HOLDING PTE.LTD.与PT KALBE FARMA TBK.控股附属公司PT GLOBAL CHEMINDO MEGATRADING签署了《SHAREHOLDERS’AGREEMENT》,公司和Kalbe通过附属公司以现金方式出资在印度尼西亚设立合资公司。公告称,本次公司对外投资在印度尼西亚设立合资公司,有利于公司拓展海外业务,符合公司中长期战略发展的目标。本次对外投资尚需取得印度尼西亚相关部门的批准,能否顺利实施尚存在不确定性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1157037.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01513","BK1191"],"gpt_icon":0},{"id":"2455651416","title":"【丽珠医药(01513.HK)及Kalbe拟通过附属公司以现金方式出资在印度尼西亚设立合资公司】智通财经APP讯,丽珠医药(01513.","url":"https://stock-news.laohu8.com/highlight/detail?id=2455651416","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455651416?lang=zh_cn&edition=full","pubTime":"2024-07-29 20:02","pubTimestamp":1722254524,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["PT","BK1191","BK4166","01513","LIAN","BK4139"],"gpt_icon":0},{"id":"2455651131","title":"丽珠医药(01513.HK)在印度尼西亚设立合资公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2455651131","media":"格隆汇资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455651131?lang=zh_cn&edition=full","pubTime":"2024-07-29 20:00","pubTimestamp":1722254454,"startTime":"0","endTime":"0","summary":"格隆汇7月29日丨丽珠医药公告,2024年7月29日,公司全资附属公司LIAN SGP HOLDING PTE.LTD.与PT KALBE FARMA,TBK.控股附属公司PT GLOBAL CHEMINDO MEGATRADING签署了《SHAREHOLDERS’AGREEMENT》,公司和Kalbe通过附属公司以现金方式出资在印度尼西亚设立合资公司。合资公司的授权资本为1,306,080,000,000印尼盾,即1,306,080股。本次公司对外投资在印度尼西亚设立合资公司,有利于公司拓展海外业务,符合公司中长期战略发展的目标。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407292001039ef6c9d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407292001039ef6c9d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01513","BK1191"],"gpt_icon":0},{"id":"2455656871","title":"丽珠医药(01513)7月29日斥资1257.53万元回购35.18万股A股","url":"https://stock-news.laohu8.com/highlight/detail?id=2455656871","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455656871?lang=zh_cn&edition=full","pubTime":"2024-07-29 19:21","pubTimestamp":1722252111,"startTime":"0","endTime":"0","summary":"智通财经APP讯,丽珠医药(01513)发布公告,该公司于2024年7月29日斥资人民币1257.53万元回购35.18万股A股,每股回购价格为人民币35.65-35.91元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1157001.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["399300","BK1191","01513","159982"],"gpt_icon":0},{"id":"2455336656","title":"【丽珠医药(01513.HK)7月29日斥资1257.53万元回购35.18万股A股】智通财经APP讯,丽珠医药(01513.","url":"https://stock-news.laohu8.com/highlight/detail?id=2455336656","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455336656?lang=zh_cn&edition=full","pubTime":"2024-07-29 19:21","pubTimestamp":1722252111,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1191","159982","01513","399300"],"gpt_icon":0},{"id":"2454767356","title":"南向资金7月25日净买入丽珠医药10.85万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2454767356","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454767356?lang=zh_cn&edition=full","pubTime":"2024-07-26 09:31","pubTimestamp":1721957497,"startTime":"0","endTime":"0","summary":"7月25日, 南向资金增持丽珠医药10.85万股,连续3日增持。截止当日收盘,港股通共持有丽珠医药5387.32万股,占流通股17.53%。丽珠医药近5个交易日下跌4.08%,港股通累计增持0.50万股;近20个交易日下跌10.31%,港股通累计增持174.08万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407260941449eeb8fa5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407260941449eeb8fa5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01513","BK1191"],"gpt_icon":0},{"id":"2454849502","title":"【丽珠医药(01513.HK)7月25日斥资1626.26万元回购45万股A股】智通财经APP讯,丽珠医药(01513.HK)发布公告,该公司于2024年7月25日斥资人民币1626.","url":"https://stock-news.laohu8.com/highlight/detail?id=2454849502","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454849502?lang=zh_cn&edition=full","pubTime":"2024-07-25 16:50","pubTimestamp":1721897434,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["01513","159982","BK1191","399300"],"gpt_icon":0},{"id":"2454846505","title":"丽珠医药07月25日主力资金流出87万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2454846505","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454846505?lang=zh_cn&edition=full","pubTime":"2024-07-25 16:16","pubTimestamp":1721895383,"startTime":"0","endTime":"0","summary":"07月25日, 丽珠医药股价跌1.05%,报收23.50元,成交金额1007万元,换手率0.14%,振幅3.37%,量比0.80。丽珠医药今日主力资金净流出87万元,连续3日净流出,上一交易日主力净流出58万元,今日环比增加50.00%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为42.86%,平均跌幅为1.96%。该股近5个交易日下跌3.67%,主力资金累计净流出17万元;近20日主力资金累计净流入20万元,其中净流入天数为9日。该股主力净额占比0.01%,港股市场排名2438/2643。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072516172095595bca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072516172095595bca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01513","BK1191"],"gpt_icon":0},{"id":"2454613108","title":"丽珠医药7月24日斥资约1021.24万元回购A股28.1万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2454613108","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454613108?lang=zh_cn&edition=full","pubTime":"2024-07-25 09:12","pubTimestamp":1721869963,"startTime":"0","endTime":"0","summary":"丽珠医药(01513)发布公告,于2024年7月24日斥资约1021.24万元(人民币,下同)回购A股股份28.1万股,每股回购价格为36.2-36.48元。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-07-25/doc-incfiefp5482923.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-07-25/doc-incfiefp5482923.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_sina","symbols":["BK1191","01513"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.livzon.com.cn","stockEarnings":[{"period":"1week","weight":-0.004},{"period":"1month","weight":0.0355},{"period":"3month","weight":-0.0708},{"period":"6month","weight":0.0114},{"period":"1year","weight":0.0844},{"period":"ytd","weight":0.0889}],"compareEarnings":[{"period":"1week","weight":0.0199},{"period":"1month","weight":-0.0174},{"period":"3month","weight":-0.1086},{"period":"6month","weight":0.0667},{"period":"1year","weight":-0.0489},{"period":"ytd","weight":0.0225}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"丽珠医药集团股份有限公司是一家主要从事医药产品的研发、生产和销售业务的中国公司。该公司主要产品包括消化道类、心脑血管类、抗微生物药物、促性激素类等西药制剂产品以及中药制剂、原料药和中间体、诊断试剂及设备。该公司的产品销往中国境内和海外市场。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.002636},{"month":2,"riseRate":0.636364,"avgChangeRate":0.034763},{"month":3,"riseRate":0.545455,"avgChangeRate":0.026914},{"month":4,"riseRate":0.727273,"avgChangeRate":0.037935},{"month":5,"riseRate":0.363636,"avgChangeRate":0.00359},{"month":6,"riseRate":0.454545,"avgChangeRate":-0.004966},{"month":7,"riseRate":0.363636,"avgChangeRate":-0.044582},{"month":8,"riseRate":0.545455,"avgChangeRate":0.005784},{"month":9,"riseRate":0.444444,"avgChangeRate":-0.004129},{"month":10,"riseRate":0.444444,"avgChangeRate":-0.000662},{"month":11,"riseRate":0.6,"avgChangeRate":0.041113},{"month":12,"riseRate":0.5,"avgChangeRate":-0.006199}],"exchange":"SEHK","name":"丽珠医药","nameEN":"LIVZON PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"丽珠医药(01513)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供丽珠医药(01513)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"丽珠医药,01513,丽珠医药股票,丽珠医药股票老虎,丽珠医药股票老虎国际,丽珠医药行情,丽珠医药股票行情,丽珠医药股价,丽珠医药股市,丽珠医药股票价格,丽珠医药股票交易,丽珠医药股票购买,丽珠医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"丽珠医药(01513)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供丽珠医药(01513)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}